Pet medicine report lookup / Afoxolaner / Dogs

What has been reported to the FDA for Afoxolaner in dogs?

Short answer: The FDA has received 65,969 adverse event reports for dogs that name Afoxolaner. The FDA lists 2 approved animal drug applications containing Afoxolaner for dogs, the earliest approved in 2013. These are counts of reports, not a rate of side effects.
Report counts read · approval records read
Veterinary disclosure Not veterinary advice. A report to the FDA is a suspicion, not proof that a medicine caused an event, and nothing here measures how often a side effect happens. Do not start, stop or change a medicine because of this page. Talk to a licensed veterinarian who knows your animal.
Afoxolanerin dogs
65,969reports to the FDA

The FDA has received 65,969 adverse event reports for dogs that name Afoxolaner.

  1. 65,969 reports name Afoxolaner in dogs, which is 6.6% of all 1,001,380 dog reports. A report counts under every active ingredient it names.
  2. 31% are marked serious and 3.1% record a death or euthanasia; across all dog reports those figures are 29% and 5.4%.
  3. 37% are complaints that the product did not work (38% across all dog reports).
  4. The clinical signs reported most are vomiting, diarrhoea and lethargy.
  5. The FDA lists 2 approved animal drug applications containing Afoxolaner for dogs, the earliest approved in 2013.
  6. None of this is a rate. The FDA data does not record how many dogs were given Afoxolaner, so it cannot say how often any of this happens.

How the reports break down

What the reports sayReportsShare of this medicine's reportsAll dog reports
Marked seriousthe FDA record flags the report as serious20,47631%29%
Death or euthanasiathe outcome recorded in the report, with no finding of cause2,0323.1%5.4%
Did not worka complaint that the product failed to work, which the FDA files as an adverse event24,17737%38%
Seizurea seizure or convulsion is among the clinical signs4,7667.2%4.4%
Not used per labelthe report says the product was not used the way its label directs6,4269.7%21%

Where on the body do the reported signs sit?

33%11%8.9%

Not on the body: Did not work 33% Whole body 9.3%

  1. Stomach and gut33%vomiting, diarrhoea, not eating, anorexia
  2. Did not work33%lack of efficacy (ectoparasite) - tick, lack of efficacy (ectoparasite) - flea, lack of efficacy (bacteria) - borrelia, lack of efficacy (tick) and 5 more
  3. Skin and coat11%skin disorders, pruritus, itching, scratching
  4. Whole body9.3%lethargy, lethargy
  5. Brain and nerves8.9%seizure, shaking, ataxia
  6. Heart and breathing2.0%panting
  7. Behaviour1.9%behavioural disorder
  8. Blood and organ tests1.5%other abnormal test result

Each figure is a share of sign mentions among the 25 signs reported most for Afoxolaner in dogs. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.

Clinical signs reported most

  1. Vomiting16,236 25%
  2. Diarrhoea6,252 9.5%
  3. Lethargy5,703 8.6%
  4. Lack of efficacy (ectoparasite) - tick5,196 7.9%
  5. Lack of efficacy (ectoparasite) - flea4,628 7.0%
  6. Seizure4,511 6.8%
  7. Lack of efficacy (bacteria) - Borrelia3,843 5.8%
  8. Lack of efficacy (tick)3,389 5.1%

Reports received per year

7,22402013: 20 reports2014: 2,881 reports2015: 5,544 reports2016: 7,224 reports2017: 7,209 reports2018: 4,823 reports2019: 5,115 reports2020: 4,791 reports2021: 4,107 reports2022: 3,609 reports2023: 4,086 reports2024: 6,600 reports2025: 6,814 reports2026: 3,146 reports2014201620182020202220242026first approved for dogs
More reports in a year can mean more animals treated, a newer product under closer watch, or more people reporting. 2026 is a part year. The tallest bar is 7,224 reports (2016). The earliest FDA approval for dogs was in 2013.

Is it approved for dogs?

DogsFDA-approved product listed
CatsFDA-approved product listed
Other animalsnone found
FDA-approved for dogs

The FDA lists 2 approved animal drug applications containing Afoxolaner for dogs, the earliest approved in 2013.

ProductFormApproved forFirst approvedFDA application
NexgardBoehringer lngelheim Animal Health USA, Inc.Chewable Tablets RXDog2013141-406
Nexgard PlusBoehringer lngelheim Animal Health USA, Inc.Chewable Tablets RXDog2023141-554

What can you do next?

What it cost in our price study$92 to $128 at a vet officeNexGard (afoxolaner), chewable, medium dog. The same study recorded $72 at Chewy and $78 at PetMeds. Prices collected April to May 2026; quantity and method are in the study.
Seen a side effect yourself?Report itCall your veterinarian first if your animal is unwell. Then report to the drug maker or to the FDA: the FDA explains both routes. Reports like yours are what this page counts.

Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.

Where can you go from this result?

This result is one of 94 in the lookup. See Afoxolaner in cats (86 reports). Open it in the lookup to set it beside another medicine, or read how the counts were collected.

To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.

Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.

☆ Save